Ivermectin shows promise as potential COVID-19 therapy.

Summary: An FDA-approved anti-parasitic drug called Ivermectin appears to inhibit and eliminate SARS-CoV-2 in lab-grown cell cultures within 48 hours. Ivermectin shows promise as potential COVID-19 therapy. However, researchers stress the need for further testing and clinical trials in humans to confirm the effectiveness of the drug and appropriate dosage levels.

Source: Monash University

Monash scientists have shown that an anti-parasitic drug already available around the world can kill the virus within 48 hours.

Scientists from the Biomedicine Discovery Institute (BDI) showed that a single dose of the drug, Ivermectin, could stop the SARS-CoV-2 virus growing in cell culture.

This Monash University-led collaborative study was published in Antiviral Research, a peer-reviewed medical journal Antiviral Research.

Whilst shown to be effective in the lab environment, Ivermectin cannot be used in humans for COVID-19 until further testing and clinical trials have been completed to confirm the effectiveness of the drug at levels safe for human dosing. The potential use of Ivermectin to combat COVID-19 remains unproven, and depends on funding to progress the work into the next stages.

Image Credit:  Amanda Scott/Alias/Envato

read the whole article

News This Week

Stem Cell Membrane-Coated Nanoparticles in Tumor Therapy

Cell membrane-coated nanoparticles, applied in targeted drug delivery strategies, combine the intrinsic advantages of synthetic nanoparticles and cell membranes. Although stem cell-based delivery systems were highlighted for their targeting capability in tumor therapy, inappropriate [...]

Self-Healable, Human-Like Artificial Skin

Self-healable ionic sensing materials with fatigue resistance are imperative in robotics and soft electronics for extended service life. The existing artificial ionic skins with self-healing capacity were prepared by network reconfiguration, constituting low-energy amorphous [...]